Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.630
-0.450 (-8.86%)
At close: Jan 9, 2026, 4:00 PM EST
4.629
-0.001 (-0.03%)
After-hours: Jan 9, 2026, 7:52 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $33.26 million as of January 9, 2026. Its market cap has increased by 111.63% in one year.
Market Cap
33.26M
Enterprise Value
31.72M
1-Year Change
111.63%
Ranking
Category
Stock Price
$4.63
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $33.26M, a decrease of -48.26%. That is a compound annual growth rate of -14.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 33.26M | 13.42% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |